AMLXAMYLYX PHARMACEUTICALS INC
CUSIP 03237H101 · common stock
3 tracked investors held AMYLYX PHARMACEUTICALS INC (AMLX) at the end of Q3 2026, worth $442.9M in total. The largest holder was Perceptive Advisors, with 5.4% of its portfolio. RA Capital Management opened a new position this quarter.
Holders · Q3 2026
3
New holders
1
Value held
$442.9M
Quarter-end price (est.)
$29.10
Investors holding AMLX · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Perceptive Advisors Perceptive Advisors LLC | 5.36% | 10,573,735 | $307.7M | ADD+26.9% |
| RA Capital Management RA Capital Management, L.P. | 1.25% | 4,279,341 | $124.5M | NEW |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.45% | 366,968 | $10.7M | REDUCE-25.8% |